Authors: Orr, JW Roland, PY Leichter, D Orr, PF

Citation: Jw. Orr et al., Endometrial cancer: is surgical staging necessary?, CURR OPIN O, 13(5), 2001, pp. 408-412

Authors: Orr, JW Roland, PY Orr, PJ Bolen, DD Hutcheson, SL

Citation: Jw. Orr et al., Subspecialty training: does it affect the outcome of women treated for a gynecologic malignancy?, CUR OP OBST, 13(1), 2001, pp. 1-8

Authors: Navari, JR Roland, PY Keh, P Salvesen, HB Akslen, LA Iversen, OE Das, S Kothari, R Howey, S Phillips, B

Citation: Jr. Navari et al., Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de Novo methylation of the 5 ' end of the ER gene, CLIN CANC R, 6(10), 2000, pp. 4026-4032

Authors: Barnes, MN Roland, PY Straughn, M Kilgore, LC Alvarez, RD Partridge, EE

Citation: Mn. Barnes et al., A comparison of treatment strategies for endometrial adenocarcinoma: Analysis of financial impact, GYNECOL ONC, 74(3), 1999, pp. 443-447

Authors: Calhoun, EA Bennett, CL Peeples, PA Lurain, JR Roland, PY Weinstein, JM Fishman, DA

Citation: Ea. Calhoun et al., Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists, GYNECOL ONC, 71(3), 1998, pp. 369-375